journal article·2017-05-31

Dipole Orientation Matters: Longer-Circulating Choline Phosphate than Phosphocholine Liposomes for Enhanced Tumor Targeting

Shuya Li, Feng Wang, Xiaoqiu Li, Jing Chen, Xiaohan Zhang, Yucai Wang, Juewen Liu

Publisher page

Abstract

Zwitterionic phosphocholine (PC) liposomes are widely used in drug delivery because of their high biocompatibility and long blood circulation time. We herein report that by flipping the direction of the PC dipole, the resulting choline phosphate (CPe) liposomes have an even longer circulation time, as confirmed at both cellular and animal-model levels. Even when 33% cholesterol was included in the lipid formulation with a poly(ethylene glycol) layer, the CPe liposome still had a longer blood circulation time. Isothermal titration calorimetry indicates a lack of protein adsorption or PC membrane attachment for the CPe liposomes. This is different from the previously reported adhesion of CP polymers to PC lipid membranes, which may be attributed to the different ways of displaying the CP headgroup. With a longer blood circulation time, the CPe liposomes accumulated in tumors more easily than PC liposomes, which is likely due to the enhanced permeation and retention effect and tumor cell uptake. This study provides key insights into zwitterionic biointerfaces for biomedical, analytical, and materials applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The CAS Key Laboratory of Innate Immunity and Chronic Diseases, School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui 230027, China

School of Biological and Medical Engineering, Hefei University of Technology, Hefei, Anhui 230009, China

Department of Chemistry, Waterloo Institute for Nanotechnology, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada

Department of Oncology, The First Affiliate Hospital of Anhui Medical University, Hefei, Anhui 230022, China

Funding

Ministry of Education of the People's Republic of China · Natural Sciences and Engineering Research Council of Canada · National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.1002/adma.20100121510.1002/adma.201001215 ↗
2. 10.1021/cr800208y10.1021/cr800208y ↗
3. 10.1039/b910899h10.1039/b910899h ↗
4. 10.1002/smll.20130354010.1002/smll.201303540 ↗
5. 10.1166/jbn.2008.02110.1166/jbn.2008.021 ↗
6. 10.1021/nn202073m10.1021/nn202073m ↗
7. 10.1002/adma.20070197510.1002/adma.200701975 ↗
8. 10.1039/C2CS35342C10.1039/C2CS35342C ↗
9. 10.1038/258043a010.1038/258043a0 ↗
10. 10.1021/la500057j10.1021/la500057j ↗
11. 10.1002/anie.20090145210.1002/anie.200901452 ↗
12. 10.1021/ja504845f10.1021/ja504845f ↗
13. 10.1002/adfm.20150489910.1002/adfm.201504899 ↗
14. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
15. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
16. 10.1016/j.addr.2015.02.00710.1016/j.addr.2015.02.007 ↗
17. 10.1021/ja808018y10.1021/ja808018y ↗
18. 10.1038/nmat299210.1038/nmat2992 ↗
19. 10.1038/nature1537310.1038/nature15373 ↗
20. 10.1002/adma.20130063810.1002/adma.201300638 ↗
21. 10.1002/adfm.20130322210.1002/adfm.201303222 ↗
22. 10.7150/thno.1788110.7150/thno.17881 ↗
23. 10.1038/nmat327210.1038/nmat3272 ↗
24. 10.1039/C4CC08681C10.1039/C4CC08681C ↗
25. 10.1016/j.biomaterials.2013.09.05210.1016/j.biomaterials.2013.09.052 ↗
26. 10.1021/acs.biomac.6b0045510.1021/acs.biomac.6b00455 ↗
27. 10.1002/mabi.20130042510.1002/mabi.201300425 ↗
28. 10.1021/jacs.5b1315610.1021/jacs.5b13156 ↗
29. 10.1021/acsmacrolett.5b0087610.1021/acsmacrolett.5b00876 ↗
30. 10.1038/nrm233010.1038/nrm2330 ↗
31. 10.1021/ja210989h10.1021/ja210989h ↗
32. 10.1002/anie.20120419810.1002/anie.201204198 ↗
33. 10.1002/anie.20160660310.1002/anie.201606603 ↗
34. 10.1021/jacs.5b0664210.1021/jacs.5b06642 ↗
35. 10.1039/C5CC07853A10.1039/C5CC07853A ↗
36. 10.1016/j.nano.2011.06.00910.1016/j.nano.2011.06.009 ↗
37. 10.1039/C4SM01355G10.1039/C4SM01355G ↗
38. 10.1021/acsnano.5b0318410.1021/acsnano.5b03184 ↗
39. 10.1021/acsami.5b0429010.1021/acsami.5b04290 ↗
40. 10.1039/C1CS15233E10.1039/C1CS15233E ↗
41. 10.1021/nn103009310.1021/nn1030093 ↗
42. 10.1073/pnas.130580411010.1073/pnas.1305804110 ↗
43. 10.1038/nbt99410.1038/nbt994 ↗
44. 10.1016/S0168-3659(99)00248-510.1016/S0168-3659(99)00248-5 ↗
45. 10.1002/hep.184009030710.1002/hep.1840090307 ↗
46. 10.1016/j.surfrep.2006.06.00110.1016/j.surfrep.2006.06.001 ↗
47. 10.1557/mrs2006.13410.1557/mrs2006.134 ↗
48. 10.1021/acs.langmuir.6b0049310.1021/acs.langmuir.6b00493 ↗
49. 10.1039/c3tb21238f10.1039/c3tb21238f ↗
50. 10.1039/c2nr32880a10.1039/c2nr32880a ↗
51. 10.1016/j.biomaterials.2013.11.08610.1016/j.biomaterials.2013.11.086 ↗
52. 10.1002/adma.20160327610.1002/adma.201603276 ↗
53. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗